EDIT vs ORLY · rev $32.3M vs P/E 34, rev $16.71B
Editas Medicine Inc (EDIT) versus O’Reilly Automotive Inc (ORLY) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
O’Reilly Automotive Inc (ORLY) is a auto parts company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported ORLY revenue for 2024-12-31 was $16.71B. Net income was $2.39B. Revenue was up 336.0% from 2023-12-31 to 2024-12-31. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
EDIT currently screens at market cap $375.2M. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
Not investment advice. Open the EDIT and ORLY stock pages for the full models.
Not investment advice.